quantisnow
FeedTopReportsPricing
⌘K
Live feed
09:06:06·918d
NEWSRelease
Biocept Inc. logo
BioRestorative Therapies Inc. logo
Better Therapeutics Inc. logo
+9

12 Health Care Stocks Moving In Wednesday's Pre-Market Session

BIOC· Biocept Inc.BRTX· BioRestorative Therapies Inc.BTTX· Better Therapeutics Inc.BXRX· Baudax Bio Inc.BYSI· BeyondSpring Inc.ICU· SeaStar Medical Holding Corporation
Health Care
Original source

Companies

  • BIOC
    Biocept Inc.
    Health Care
  • BRTX
    BioRestorative Therapies Inc.
    Health Care
  • BTTX
    Better Therapeutics Inc.
    Health Care
  • BXRX
    Baudax Bio Inc.
    Health Care
  • BYSI
    BeyondSpring Inc.
    Health Care
  • ICU
    SeaStar Medical Holding Corporation
    Health Care
  • IONM
    Assure Holdings Corp.
    Health Care
  • NXL
    Nexalin Technology Inc.
    Health Care
  • RVLP
    RVL Pharmaceuticals plc
    Health Care
  • SNPX
    Synaptogenix Inc.
    Health Care
  • TPST
    Tempest Therapeutics Inc.
    Health Care
  • YTEN
    Yield10 Bioscience Inc.

Recent analyst ratings

  • Jan 22TPSTUpdateH.C. Wainwright$11.00
  • Apr 10TPSTUpdateScotiabank-
  • Apr 10TPSTUpdateH.C. Wainwright-
  • Mar 14TPSTUpdateScotiabank$13.00
  • Feb 8YTENUpdateLake Street-
  • Feb 8TPSTUpdateJefferies$15.00

Related

  • SEC8h
    BioRestorative Therapies Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • SEC1d
    Nexalin Technology Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits
  • PR1d
    Tempest Announces Key Manufacturing Milestone for TPST-2003 Dual-Targeting CD19/BCMA CAR-T
  • PR1d
    BeyondSpring Reports Compelling New Data: Plinabulin Advances Both the Anticancer Efficacy and Safety of ADC Drugs
  • PR2d
    BioRestorative Therapies Announces Strategic Partnership with Global Dermatology Leader Dr. David J. Goldberg to Lead Clinical Evaluation and Seek Multi-Channel Adoption of Its Regenerative BioCosmeceutical Platform
  • SEC3d
    SEC Form POS AM filed by BioRestorative Therapies Inc.
  • PR8d
    Nexalin Advances FDA Alzheimer's Strategy Following Landmark Leadership Meetings in the U.S. and China
  • PR9d
    Join Nexalin's Exclusive Live Investor Webinar and Q&A Session on April 21
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022